一种编码蛋白质的CCDC7循环RNA通过上调FLRT3来抑制前列腺癌的进展
Qiong Wang1,2, Bisheng Cheng3, Sandeep Singh2
1Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
NPJ precision oncology
|January 15, 2024
概括
一种新型的蛋白质编码圆形RNA,circCCDC7,在前列腺癌中起到瘤抑制作用. 它编码的蛋白质抑制了癌细胞的迁移和入侵,提供了潜在的治疗应用.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 循环RNAs (circRNAs) 越来越多地被认为具有不同的生物作用,包括基因调节.
- 环RNAs的蛋白质编码潜力在很大程度上仍未被探索,这代表了新型蛋白质的潜在来源.
- 前列腺癌的进展与复杂的分子变化有关,需要确定新的治疗点.
研究的目的:
- 在前列腺癌中识别和描述新的蛋白质编码circRNAs.
- 在前列腺癌中研究circCCDC7的功能作用.
- 探索circCCDC7 ((15,16,17,18,19) 和其编码蛋白的治疗潜力.
主要方法:
- 生物信息分析以确定候选circRNAs.
- 分子克隆和证实circCCDC7的有效性.
- 在体外测试以评估细胞迁移,入侵和活力.
- 西方斑点和有条件介质实验以确认蛋白质分泌和功能.
主要成果:
- circCCDC7 ((15,16,17,18,19) 被确定为一种来自CCDC7基因的编码蛋白 circRNA.
- circCCDC7 ((15,16,17,18,19) 表达在高格里森评分前列腺癌中下调,与预后不佳相关.
- 过度表达circCCDC7 ((15,16,17,18,19) 抑制前列腺癌细胞迁移,入侵和活力,作为瘤抑制剂.
- 瘤抑制活性由分泌的蛋白质 (circCCDC7-180aa) 介导,这也影响了FLRT3的表达.
结论:
- circCCDC7 ((15,16,17,18,19) 是前列腺癌中的瘤抑制剂,通过其编码的分泌蛋白发挥作用.
- circCCDC7-180aa代表了一种用于前列腺癌治疗的新型治疗性.
- circCCDC7 ((15,16,17,18,19) 和其蛋白质产品对未来的前列腺癌疗法充满希望.
相关概念视频
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


